Literature DB >> 23268518

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Gilda Piaggio1, Diana R Elbourne, Stuart J Pocock, Stephen J W Evans, Douglas G Altman.   

Abstract

The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors improve the reporting of the findings from randomized controlled trials. It was updated most recently in 2010. Its primary focus is on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another. The CONSORT Statement has been extended to other trial designs such as cluster randomization, and recommendations for noninferiority and equivalence trials were made in 2006. In this article, we present an updated extension of the CONSORT checklist for reporting noninferiority and equivalence trials, based on the 2010 version of the CONSORT Statement and the 2008 CONSORT Statement for the reporting of abstracts, and provide illustrative examples and explanations for those items that differ from the main 2010 CONSORT checklist. The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the reliability of their results and conclusions.

Entities:  

Mesh:

Year:  2012        PMID: 23268518     DOI: 10.1001/jama.2012.87802

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  321 in total

1.  Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study.

Authors:  T Piche; M Dapoigny
Journal:  United European Gastroenterol J       Date:  2020-06-28       Impact factor: 4.623

2.  [Minimum requirements for high quality reporting of medical research results : CONSORT, STROBE and PRISMA statements].

Authors:  A Stevanovic; M Coburn; R Rossaint
Journal:  Anaesthesist       Date:  2015-12       Impact factor: 1.041

3.  Radiation de-intensification for patients with glioblastoma and poor prognostic features--how much do we really know?

Authors:  Brian Michael Alexander
Journal:  Neuro Oncol       Date:  2016-02       Impact factor: 12.300

4.  Re: The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).

Authors:  E Lancelot; B Piednoir; P Desché
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-14       Impact factor: 3.825

Review 5.  Epidemiology research in rheumatology-progress and pitfalls.

Authors:  Deborah P M Symmons
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

6.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

7.  Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.

Authors:  Amit X Garg; Neal Badner; Sean M Bagshaw; Meaghan S Cuerden; Dean A Fergusson; Alexander J Gregory; Judith Hall; Gregory M T Hare; Boris Khanykin; Shay McGuinness; Chirag R Parikh; Pavel S Roshanov; Nadine Shehata; Jessica M Sontrop; Summer Syed; George I Tagarakis; Kevin E Thorpe; Subodh Verma; Ron Wald; Richard P Whitlock; C David Mazer
Journal:  J Am Soc Nephrol       Date:  2019-06-20       Impact factor: 10.121

8.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

9.  Remote delivery of weight management for adults with intellectual and developmental disabilities: Rationale and design for a 24 month randomized trial.

Authors:  Lauren T Ptomey; Richard A Washburn; Matthew S Mayo; J Leon Greene; Robert H Lee; Amanda N Szabo-Reed; Jeffery J Honas; Joseph R Sherman; Joseph E Donnelly
Journal:  Contemp Clin Trials       Date:  2018-08-24       Impact factor: 2.226

10.  Effectiveness of Guided Internet-Based Cognitive Behavioral Therapy vs Face-to-Face Clinical Care for Treatment of Tinnitus: A Randomized Clinical Trial.

Authors:  Eldré W Beukes; Gerhard Andersson; Peter M Allen; Vinaya Manchaiah; David M Baguley
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.